Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Malignant Rhabdoid Tumor (MRT)

Tundra lists 1 Malignant Rhabdoid Tumor (MRT) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05407441

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

This research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor, epithelioid sarcoma, chordoma or other tumors that are deficient in one of two possible proteins, either INI-1 (SMARCB1) or SMARCA4. The names of the study drugs involved in this study are: * Tazemetostat (TAZVERIK) * Nivolumab (OPDIVO) * Ipilimumab (YERVOY)

Gender: All

Ages: 6 Months - 21 Years

Updated: 2025-10-03

2 states

Atypical Teratoid Rhabdoid Tumor

INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors

SMARCA4-deficient Primary CNS Malignant Tumors